Literature DB >> 12832436

20 years with ANCA (antineutrophil cytoplasmic autoantibodies): from seromarker to a major pathogenic player in vasculitis.

Bernhard Hellmich, Elena Csernok, Wolfgang L Gross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832436     DOI: 10.1189/jlb.0403134

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  6 in total

Review 1.  [Early diagnosis of chronic systemic inflammatory disorders].

Authors:  B Hellmich; F Merkel; M Weber; W L Gross
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

2.  Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis.

Authors:  S Ohlsson; T Hellmark; K Pieters; G Sturfelt; J Wieslander; M Segelmark
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

3.  Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils.

Authors:  S C Hsieh; H S Yu; S H Cheng; K J Li; M C Lu; C H Wu; C Y Tsai; C L Yu
Journal:  Clin Rheumatol       Date:  2006-03-31       Impact factor: 2.980

4.  The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.

Authors:  K Pieters; A Pettersson; U Gullberg; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  Stable incidence of systemic vasculitides in schleswig-holstein, Germany.

Authors:  Karen Herlyn; Bernhard Hellmich; Wolfgang L Gross; Eva Reinhold-Keller
Journal:  Dtsch Arztebl Int       Date:  2008-05-09       Impact factor: 5.594

6.  Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?

Authors:  Sophie Ohlsson; Jörgen Wieslander; Mårten Segelmark
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.